Anavex Life Sciences
AVXL
#7751
Rank
โ‚น31.15 B
Marketcap
โ‚น348.64
Share price
0.13%
Change (1 day)
-52.89%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -โ‚น46.61

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -โ‚น48.33. In 2024 the company made an earnings per share (EPS) of -โ‚น46.54 an increase over its 2023 EPS that were of -โ‚น53.71.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น46.610.14%
2024-โ‚น46.54-13.33%
2023-โ‚น53.71-3.23%
2022-โ‚น55.5014.81%
2021-โ‚น48.3320%
2020-โ‚น40.28-16.67%
2019-โ‚น48.3338.46%
2018-โ‚น34.9118.18%
2017-โ‚น29.54-21.43%
2016-โ‚น37.59-35.38%
2015-โ‚น58.18-36.27%
2014-โ‚น91.30112.5%
2013-โ‚น42.96-58.62%
2012-โ‚น103.83-0%
2011-โ‚น103.83-29.27%
2010-โ‚น146.7951.85%
2009-โ‚น96.67-0%
2008-โ‚น96.67237.5%
2007-โ‚น28.64
2006N/A-100%
2005-โ‚น3.58499.97%
2004-โ‚น0.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น213.93-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.48-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น89.51-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น2,676 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA